# Atara Biotherapeutics, Inc. (ATRA): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Atara Biotherapeutics, Inc. (ATRA) is 27/100, ranked against 24,000+ stocks in 35 markets (Quality 25, Value 24, Momentum 63, each scored against its sector).

- StockRank: 27/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 25, Value 24, Momentum 63: each a 0-100 percentile within Healthcare.
- Position: #19,396 overall, #1,705 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 8.35 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1000K; directors sold USD 111K.

Source: https://moatmap.ai/stock/ATRA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker